These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21770891)

  • 1. The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands.
    Xu TR; Ward RJ; Pediani JD; Milligan G
    Biochem J; 2011 Oct; 439(1):171-83. PubMed ID: 21770891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
    Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
    Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
    Xu TR; Ward RJ; Pediani JD; Milligan G
    J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.
    Ward RJ; Pediani JD; Milligan G
    J Biol Chem; 2011 Oct; 286(43):37414-28. PubMed ID: 21908614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
    Ward RJ; Pediani JD; Milligan G
    Br J Pharmacol; 2011 Mar; 162(6):1439-52. PubMed ID: 21175569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.
    Putula J; Turunen PM; Johansson L; Näsman J; Ra R; Korhonen L; Kukkonen JP
    FEBS Lett; 2011 May; 585(9):1368-74. PubMed ID: 21510948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras.
    Putula J; Kukkonen JP
    Neurosci Lett; 2012 Jan; 506(1):111-5. PubMed ID: 22079339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
    Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
    Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
    Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
    J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of TRPC3 channels in calcium oscillations mediated by OX(1) orexin receptors.
    Peltonen HM; Magga JM; Bart G; Turunen PM; Antikainen MS; Kukkonen JP; Akerman KE
    Biochem Biophys Res Commun; 2009 Jul; 385(3):408-12. PubMed ID: 19464259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide and GABA mediate bi-directional cardiovascular effects of orexin in the nucleus tractus solitarii of rats.
    Shih CD; Chuang YC
    Neuroscience; 2007 Nov; 149(3):625-35. PubMed ID: 17916408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats.
    Chang H; Saito T; Ohiwa N; Tateoka M; Deocaris CC; Fujikawa T; Soya H
    Neurosci Res; 2007 Mar; 57(3):462-6. PubMed ID: 17188385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1.
    Magga J; Bart G; Oker-Blom C; Kukkonen JP; Akerman KE; Näsman J
    Biochem Pharmacol; 2006 Mar; 71(6):827-36. PubMed ID: 16430869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes.
    Jöhren O; Gremmels JA; Qadri F; Dendorfer A; Dominiak P
    Peptides; 2006 Nov; 27(11):2764-9. PubMed ID: 16822588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for PKD1 and PKD3 activation in modulation of calcium oscillations induced by orexin receptor 1 stimulation.
    Peltonen HM; Akerman KE; Bart G
    Biochim Biophys Acta; 2010 Oct; 1803(10):1206-12. PubMed ID: 20621130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.
    Holland PR; Akerman S; Goadsby PJ
    Eur J Neurosci; 2006 Nov; 24(10):2825-33. PubMed ID: 17156207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
    Voisin T; Firar AE; Avondo V; Laburthe M
    Endocrinology; 2006 Oct; 147(10):4977-84. PubMed ID: 16857748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB-334867-A: the first selective orexin-1 receptor antagonist.
    Smart D; Sabido-David C; Brough SJ; Jewitt F; Johns A; Porter RA; Jerman JC
    Br J Pharmacol; 2001 Mar; 132(6):1179-82. PubMed ID: 11250867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.